CARDIFF ONCOLOGY, INC. Proceeds from (Payments for) Other Financing Activities
CARDIFF ONCOLOGY, INC. (CRDF) reported Proceeds from (Payments for) Other Financing Activities of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2022-02-24
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for the quarter ending 2021-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for the quarter ending 2021-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for the quarter ending 2020-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for the quarter ending 2020-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for fiscal 2021 was $0.00.
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for fiscal 2020 was -$8.00K.
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for fiscal 2019 was -$40.00K.
- CARDIFF ONCOLOGY, INC. proceeds from (payments for) other financing activities for fiscal 2018 was $0.00.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 6 month as first filed | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 9 month as first filed | Proceeds from (Payments for) Other Financing Activities 12 month | Proceeds from (Payments for) Other Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | -$8.00K derived: sum of 3 quarters · filed 2022-02-24 | -$8.00K 10-K · filed 2022-02-24 | -$7.50K 10-K · filed 2021-02-25 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$8.00K derived: sum of 2 quarters · filed 2021-11-04 | -$8.00K 10-Q · filed 2021-11-04 | -$7.50K 10-Q · filed 2020-11-05 | -$8.00K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$8.00K 10-Q · filed 2021-08-05 | -$7.50K 10-Q · filed 2020-08-11 | -$8.00K derived: sum of 3 quarters · filed 2021-08-05 | -$8.00K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | -$40.00K 10-K · filed 2021-02-25 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | -$40.00K 10-Q · filed 2020-11-05 | -$40.00K derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$40.00K 10-Q · filed 2020-08-11 | -$40.00K derived: sum of 3 quarters · filed 2020-08-11 | -$40.00K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$40.00K 10-Q · filed 2020-05-07 | -$40.00K derived: sum of 2 quarters · filed 2020-05-07 | -$40.00K derived: sum of 3 quarters · filed 2020-05-07 | -$40.00K derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |